Aquestive Therapeutics is a biopharmaceutical company that specializes in oral delivery of complex molecules using its proprietary PharmFilm® technology. The company develops and manufactures licensed products, collaborating with partners to bring new drugs to market and holds exclusive manufacturing rights for these products worldwide. Its pipeline features a late‑stage candidate for severe allergic reactions, including anaphylaxis, and an early‑stage topical epinephrine prodrug for dermatological conditions such as alopecia areata. Aquestive’s unique value proposition lies in converting complex therapeutics into convenient, non‑invasive oral formulations, thereby improving patient adherence and reducing the need for invasive treatments. Proven drug development and commercialization capabilities further strengthen its position as an industry innovator.
As a field-based medical expert, the Medical Science Liaison (MSL) supports AQST's therapeutic areas of interest, programs, and approved products by advancing scientific and medical relationships and educating external and internal stakeholders on the science behind the safe and appropriate use of our products.
Aquestive Therapeutics is a biopharmaceutical company that specializes in oral delivery of complex molecules using its proprietary PharmFilm® technology. The company develops and manufactures licensed products, collaborating with partners to bring new drugs to market and holds exclusive manufacturing rights for these products worldwide. Its pipeline features a late‑stage candidate for severe allergic reactions, including anaphylaxis, and an early‑stage topical epinephrine prodrug for dermatological conditions such as alopecia areata. Aquestive’s unique value proposition lies in converting complex therapeutics into convenient, non‑invasive oral formulations, thereby improving patient adherence and reducing the need for invasive treatments. Proven drug development and commercialization capabilities further strengthen its position as an industry innovator.
Mallinckrodt Pharmaceuticals